Literature DB >> 10178654

Applications of modelling studies.

M J Nuijten1, J Starzewski.   

Abstract

There is increasing use of economic evaluation to support decision-makers in health services for allocation of scarce healthcare resources. However, information necessary for economic evaluations cannot always be derived from well-conducted prospective clinical studies, and decision-analytical models can be used to provide some of the missing information. A number of applications of decision-analytical models are discussed, including submissions to authorities for reimbursement purposes, pharmacoeconomic programme development, portfolio investment decisions, marketing and communication strategies, and applications in disease management.

Mesh:

Year:  1998        PMID: 10178654     DOI: 10.2165/00019053-199813030-00003

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  2 in total

Review 1.  The selection of data sources for use in modelling studies.

Authors:  M J Nuijten
Journal:  Pharmacoeconomics       Date:  1998-03       Impact factor: 4.981

2.  The Markov process in medical prognosis.

Authors:  J R Beck; S G Pauker
Journal:  Med Decis Making       Date:  1983       Impact factor: 2.583

  2 in total
  5 in total

1.  Pharmacy benefit management: enhancing the applicability of pharmacoeconomics for optimal decision making.

Authors:  C Daniel Mullins; Junling Wang
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

Review 2.  Assessing quality in decision analytic cost-effectiveness models. A suggested framework and example of application.

Authors:  M Sculpher; E Fenwick; K Claxton
Journal:  Pharmacoeconomics       Date:  2000-05       Impact factor: 4.981

3.  The incorporation of potential confounding variables in Markov models.

Authors:  Mark J C Nuijten; Frans Rutten
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

Review 4.  Current challenges in health economic modeling of cancer therapies: a research inquiry.

Authors:  Jeffrey D Miller; Kathleen A Foley; Mason W Russell
Journal:  Am Health Drug Benefits       Date:  2014-05

Review 5.  Model-based cost-effectiveness analyses for prostate cancer chemoprevention : a review and summary of challenges.

Authors:  Stephanie R Earnshaw; Andrew P Brogan; Cheryl L McDade
Journal:  Pharmacoeconomics       Date:  2013-04       Impact factor: 4.981

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.